Dechert LLP advised Medtech, a French company specializing in the design and development of surgical assistance robots listed on Euronext Paris, in the issuance of its convertible notes to Ally Bridge Group. Medtech announced an issue of convertible notes and warrants to Ally Bridge Group, a global healthcare-focused investment group based in New York and Hong Kong. With this transaction, Medtech aims to continue its geographic expansion, particularly within the U.S. market, while financing the development of its products and research and development.

The Dechert team advising Medtech was led by partner Matthieu Grollemund assisted by associates Quentin Durand, Judith Malka, Raphael Sendowski and Michael J. Rosenberg for transactional aspects and Antoine Le Touzé for tax issues.